ObaCell® ASC Fat-on-a-Chip Kit
Research tool for metabolic disease modeling (e.g., obesity), cancer microenvironment studies, drug screening
Key Facts
About Obatala Sciences
Obatala Sciences is a private, early-stage biotech company founded in 2017 and based in New Orleans, operating in the regenerative medicine and cell therapy sectors. The company has developed a proprietary platform centered on human-derived hydrogels (ObaGel®) and adipose tissue models (ObaCell®) to create physiologically relevant organ-on-a-chip systems for disease modeling and drug screening. Its core value proposition is enhancing preclinical research accuracy by capturing human biological diversity, thereby aiming to reduce drug development costs and failures. Obatala appears to be in an early revenue or pre-revenue stage, generating income through the sale of research kits and materials to the academic and pharmaceutical R&D markets.
View full company profile